Synthetic mRNA is viewed as a viable and functional replacement for mature mRNA in both in vitro and in vivo research projects, including therapeutic development and delivery. Our comprehensive offering of premier tools and reagents helps you realize the potential of synthetic mRNA in your biopharmaceutical and life science research applications.
We provide a diverse portfolio of premium products to aid in your research, from tools and kits to isolate and purify total RNA to cells and enzymes that accelerate the synthesis of mRNA.
mRNA has demonstrated significant potential for the development of therapeutic approaches in infectious disease, genetic conditions, heart disease, oncology, and more. We support mRNA antigen discovery with:
For in vitro delivery of mRNA for applications such as stem cell induction, protein replacement, cancer immunotherapies, or vaccine modalities, synthetic mRNA has become a critical tool in diverse biopharmaceutical approaches. Our portfolio of mRNA synthesis products includes:
Lipid nanoparticles (LNPs) are critical vehicles for mRNA delivery - encapsulating and conveying mRNA safely to cells. LNP selection is integral at the earliest stages of vaccine and therapeutic mRNA delivery research. We offer a comprehensive portfolio for lipid selection and LNP formulation, including: